- Home
- PRTG
PRTG
Portage Biotech Inc.
as 11-22-2024 3:38pm EST
Portage Biotech Inc is engaged in researching and developing pharmaceutical and biotech products through clinical proof of concept with an initial focus on unmet clinical needs. It is an immune-oncology company focused on overcoming immune resistance and currently managing 10 immuno-oncology assets at various development stages. Its pipeline products include IMM-60; IMM60 + Cell Therapy; (IMM60 / NY-ESO-1) + Keytruda and others.
| Founded: | 1973 | Country: | British Virgin Islands |
| Employees: | N/A | City: | N/A |
| Market Cap: | 4.7M | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 42.8K |
| Analyst Decision: | Hold | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -70.50 | EPS Growth: | N/A |
| 52 Week Low/High: | $2.10 - $40.80 | Next Earning Date: | 12-03-2024 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Portage Biotech Inc. News
PRTG Breaking Stock News: Dive into PRTG Ticker-Specific Updates for Smart Investing
Simply Wall St.
5 days ago
Portage Biotech's Market Cap Drops To US$4.3m Leaving Insiders With Losses
MT Newswires
2 months ago
Top Premarket Gainers
GlobeNewswire
3 months ago
Portage Biotech Reports Results for Fiscal Quarter Ended June 30, 2024 and Business Update
GlobeNewswire
3 months ago
Portage Biotech Reports Fiscal Year-Ended March 31, 2024 Financial Results and Business Update
GlobeNewswire
3 months ago
Portage Biotech Announces 1-for-20 Reverse Stock Split
MT Newswires
5 months ago
Converge Technology Solutions Rating, Price Target Left Unchanged by National Bank Following Deconsolidation of Portage CyberTech
GlobeNewswire
7 months ago
Portage Biotech Announces Plans to Expand its Evaluation of Strategic Alternatives
GlobeNewswire
8 months ago
Portage Biotech Completes Monetization of Intensity Therapeutics (INTS) shares
Compare PRTG vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "PRTG Portage Biotech Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.